Abstract
BCL2L12, a newly identified member of Bcl-2 family, and its transcript variant BCL2L12A have been found to be associated with favorable prognosis in breast cancer patients while correlated with tumorigenesis of glioblastoma and colon cancer. However, the biological functions of BCL2L12 and especially those of BCL2L12A are largely unknown. Here, we report that, unlike other Bcl-2 family proteins, BCL2L12 and its transcript variant BCL2L12A are nuclear proteins. Interestingly, BCL2L12 forms speckle patterns in the nuclei and potently induces apoptosis in CHO cells. BCL2L12A had a diffuse distribution in the nuclei and inhibits cell growth by inducing cell cycle arrested at G2/M transition in CHO cells. More importantly, BCL2L12A-induced G2/M arrest was associated with a slight up-regulation of cyclin B1 and significant down-regulation of an active form of cyclin B1 phosphorylated at Ser147. Taken together, our study suggests that both BCL2L12 and BCL2L12A have negative effects on CHO cell growths, and that BCL2L12A is a potential cell cycle regulator that interferes with G2–M transition.
Similar content being viewed by others
References
Scorilas A, Kyriakopoulou L, Yousef GM, Ashworth LK, Kwamie A, Diamandis EP (2001) Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. Genomics 72:217–221
G.L.Toumelin, Mazars A, Licznar A, Guasconi G, Rain JC, Cauquil N, John H, Olivier G (2006) Bcl2L12, a new BH2 BH3 containing protein, substrate for GSK3beta, mediates UV induced apoptosis. Proc Am Assoc Cancer Res 47. (Abstract No 4073)
Floros KV, Thomadaki H, Lallas G, Katsaros N, Talieri M, Scorilas A (2003) Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12. Ann N Y Acad Sci 1010:153–158
Floros KV, Thomadaki H, Katsaros N, Talieri M, Scorilas A (2004) mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem 385:1099–1103
Floros KV, Talieri M, Scorilas A (2006) Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol Chem 387:1629–1633
Floros KV, Thomadaki H, Florou D, Talieri M, Scorilas A (2006) Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide. Ann N Y Acad Sci 1090:89–97
Thomadaki H, Talieri M, Scorilas A (2006) Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biol Chem 387:1081–1086
Thomadaki H, Scorilas A (2007) Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann N Y Acad Sci 1095:35–44
Hong Y, Yang J, Wu W, Wang W, Kong X, Wang Y, Yun X, Zong H, Wei Y, Zhang S, Gu J (2008) Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells. Biochim Biophys Acta 1782:649–657
Talieri M, Diamandis EP, Katsaros N, Gourgiotis D, Scorilas A (2003) Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Thromb Haemost 89:1081–1088
Mathioudaki K, Scorilas A, Papadokostopoulou A, Xynopoulos D, Arnogianaki N, Agnanti N, Talieri M (2004) Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Biol Chem 385:779–783
Stegh AH, Kesari S, Mahoney JE, Jenq HT, Forloney KL, Protopopov A, Louis DN, Chin L, DePinho RA (2008) Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA 105:10703–10708
Stegh AH, Kim H, Bachoo RM, Forloney KL, Zhang J, Schulze H, Park K, Hannon GJ, Yuan J, Louis DN, DePinho RA, Chin L (2007) Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev 21:98–111
Marx J (1991) The cell cycle: spinning farther afield. Science 252:1490–1492
Fang F, Newport JW (1991) Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 66:731–742
Miller ME, Cross FR (2001) Cyclin specificity: how many wheels do you need on a unicycle? J Cell Sci 114:1811–1820
Toyoshima F, Moriguchi T, Wada A, Fukuda M, Nishida E (1998) Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J 17:2728–2735
Jin P, Hardy S, Morgan DO (1998) Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 141:875–885
Li J, Meyer AN, Donoghue DJ (1997) Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation. Proc Natl Acad Sci USA 94:502–507
Toyoshima-Morimoto F, Taniguchi E, Shinya N, Iwamatsu A, Nishida E (2001) Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 410:215–220
Sun M, Wei Y, Yao L, Xie J, Chen X, Wang H, Jiang J, Gu J (2006) Identification of extracellular signal-regulated kinase 3 as a new interaction partner of cyclin D3. Biochem Biophys Res Commun 340:209–214
Chen S, Yin X, Zhu X, Yan J, Ji S, Chen C, Cai M, Zhang S, Zong H, Hu Y, Yuan Z, Shen Z, Gu J (2003) The C-terminal kinase domain of the p34cdc2-related PITSLRE protein kinase (p110C) associates with p21-activated kinase 1 and inhibits its activity during anoikis. J Biol Chem 278:20029–20036
Lai CF, Feng X, Nishimura R, Teitelbaum SL, Avioli LV, Ross FP, Cheng SL (2000) Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J Biol Chem 275:36400–36406
Jia L, Macey MG, Yin Y, Newland AC, Kelsey SM (1999) Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood 93:2353–2359
Murray A (1995) Cyclin ubiquitination: the destructive end of mitosis. Cell 81:149–152
Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS (2008) Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. J Pharmacol Exp Ther 325:841–849
O’Brien V, Brown R (2006) Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27:682–692
Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39:615–647
Huang DC, O’Reilly LA, Strasser A, Cory S (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 16:4628–4638
Chattopadhyay A, Chiang CW, Yang E (2001) BAD/BCL-[X(L)] heterodimerization leads to bypass of G0/G1 arrest. Oncogene 20:4507–4518
O’Reilly LA, Huang DC, Strasser A (1996) The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 15:6979–6990
Linette GP, Li Y, Roth K, Korsmeyer SJ (1996) Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93:9545–9552
Borner C (1996) Diminished cell proliferation associated with the death-protective activity of Bcl-2. J Biol Chem 271:12695–12698
Mazel S, Burtrum D, Petrie HT (1996) Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 183:2219–2226
Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ, Zhu L, Chittenden T (2001) Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 98:11318–11323
Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683–694
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053–1058
Wu X, Deng Y (2002) Bax and BH3-domain-only proteins in p53-mediated apoptosis. Front Biosci 7:d151–d156
Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7:673–682
Akao Y, Otsuki Y, Kataoka S, Ito Y, Tsujimoto Y (1994) Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res 54:2468–2471
Massaad CA, Portier BP, Taglialatela G (2004) Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2. J Biol Chem 279:54470–54478
von MA (2006) The nuclear ubiquitin-proteasome system. J Cell Sci 119:1977–1984
Acknowledgments
This work was supported by National Natural Scientific Foundation of China (30770426), Shanghai Leading Academic Discipline Project (B110), National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No.J0730860), and State Key Project Specialized for Infectious Diseases (2008ZX10002-015, 2008ZX10002-021, 2008ZX10001-02).
Author information
Authors and Affiliations
Corresponding author
Additional information
Yi Hong and Junwu Yang have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11010_2009_233_MOESM1_ESM.jpg
Supplement Fig. 1 Ectopic expression of BCL2L12 induces apoptosis in CHO cells. EGFP or EGFP-tagged BCL2L12 were transiently transfected into CHO cells. (A) 48 hours after transfection, cells were lysed and subjected to Western blot analysis for indicated proteins. (B) All the adherent and non-adherent cells were harvested and subject to FACS analysis as described in “Materials and Methods”. (C) Statistical analysis of cell apoptotic rate from three independent experiments (JPG 105 kb)
11010_2009_233_MOESM2_ESM.jpg
Supplement Fig. 2 Knockdown of BCL2L12 and BCL2L12A did not affect cell cycle progression in MDA-MB-231 cells. (A) Cell cycle distributions of MDA-MB-231/pSilencer and MDA-MB-231/pSi-BCL2L12 cells. (B) Statistical analysis of cell cycle distributions of MDA-MB-231/pSi and MDA-MB-231/pSi-BCL2L12 cells. The data shown are means ± SD of three independent experiments. (C) Lysates of MDA-MB-231/pSilencer and MDA-MB-231/pSi-BCL2L12 cells were subjected to Western blot analysis with antibodies against cell cycle associated proteins (JPG 124 kb)
Rights and permissions
About this article
Cite this article
Hong, Y., Yang, J., Chi, Y. et al. BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells. Mol Cell Biochem 333, 323–330 (2010). https://doi.org/10.1007/s11010-009-0233-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0233-z